Published in

American Heart Association, Circulation: Arrhythmia and Electrophysiology, 5(2), p. 562-570, 2009

DOI: 10.1161/circep.108.833442

Links

Tools

Export citation

Search in Google Scholar

Short-Term Memory and Restitution During Ventricular Fibrillation in Human Hearts An In Vivo Study

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background— Action potential duration (APD) variation is an important determinant of wave break and reentry. The determinants of APD variability during early ventricular fibrillation (VF) in myopathic human hearts have not been studied. The objective of this study was to study the role of APD restitution and short-term cardiac memory on variation in human VF. Methods and Results— The study consisted of 7 patients (67�9 years old) with ejection fraction <35%. Monophasic action potentials were recorded from the right and/or left ventricular septum during VF. APD 60/90 was measured in sinus beat preceding induction of VF, and its amplitude was used to define 60%/90% repolarization in VF. The monophasic action potential upstroke (dV/dt max ) was used to characterize local excitability. Simple linear regression showed that variability in APD n60 was determined by APD/diastolic interval restitution ( R 2 =0.48, P <0.0001) and short-term memory (APD 60 n−1, n−2, n−3, n−4; R 2 =0.55, 0.40, 0.33, and 0.27 respectively; P <0.001). Using multiple stepwise regression, short-term memory and restitution accounted for 62% of variance in APD 60 ( P <0.001). Individually, memory effect had the greatest contribution to APD variability ( R 2 =0.55, P <0.0001). Conclusions— In early human VF, short-term memory and APD/diastolic interval restitution explain most of the APD variability, with memory effects predominating. This suggests that in early human VF, short-term cardiac memory may provide a novel therapeutic target to modulate progression of VF in myopathic patients.